Expanding the Market Through Fear

There’s a good article in Vanity Fair about the scandal at Valeant, the pharmaceuticals maker. NPR has also covered this for those not interested in reading. http://www.vanityfair.com/news/2016/06/the-valeant-meltdown-and-wall-streets-major-drug-problem The part that has everyone up in arms has to do with their pricing strategy. The examples given are Syprine and Cuprimine, for

Continue reading »

JSM 2016

I received word back from the 2016 Joint Statistical Meetings. As noted back in February, I proposed to JSM a presentation on retrospective social discount rates. This came from my dissertation and you can read more about it there. Yesterday, I got word that my proposal had been accepted for

Continue reading »